Several SRT agents have been developed and are currently in use:
Miglustat: A well-known SRT agent used to treat Gaucher Disease and Niemann-Pick Disease Type C. Eliglustat: Another SRT agent for Gaucher Disease Type 1, offering an alternative with potentially fewer side effects.
